Fulton G J, Davies M G, Barber L, Gray J L, Svendsen E, Hagen P O
Department of Surgery, Duke University Medical Center, North Carolina 27710, USA.
Eur J Vasc Endovasc Surg. 1998 Apr;15(4):279-89. doi: 10.1016/s1078-5884(98)80030-0.
The universal response of vein grafts after insertion into the arterial circulation is the development of intimal hyperplasia; smooth muscle cell proliferation and connective tissue deposition, which may be modulated in part by dysfunctional endothelial nitric oxide (NO) metabolism. This study examines the effects of single dose, local application by pluronic gel of a NO donor, S-nitroso-N-acetylpenicillamine (SNAP) and an NO synthase inhibitor nitro-L-arginine methyl ester (L-NAME) on the formation of intimal hyperplasia.
Forty New Zealand white rabbits underwent jugular vein interposition grafting of the common carotid artery.
Ten animals were controls, 10 animals had the outer surface of the vein graft coated with 30% pluronic gel (2.5 ml), and 10 each were immersed for 15 min prior to insertion in Ringer lactate containing 10(-3) M of SNAP or L-NAME and then had their vein grafts coated with 2.5 ml of gel containing either SNAP (10(-3) M) or L-NAME (10(-3) M), which allows for sustained delivery for up to 6 h. On the 28th post operative day, the animals were sacrificed and vein grafts were harvested for morphology by electron microscopy (SEM and TEM) and dimensional analysis by videomorphometry.
All vein grafts developed intimal hyperplasia. On SEM the vein grafts had a confluent layer of endothelial cells with multiple layers of smooth muscle cells representing intimal hyperplasia in TEM. There were no demonstrable morphological differences between the four groups. Local treatment with SNAP produced a significant 36% decrease in mean intimal thickness (72 +/- 4 microns vs. 45 +/- 4 microns; mean +/- S.E.M.; p < 0.01) without a change in medial thickness compared to gel-only treated groups (58 +/- 6 microns vs. 61 +/- 7 microns; p = ns). Inhibition of NO synthase by L-NAME had no effect on the development of intimal hyperplasia (72 +/- 4 microns vs. 79 +/- 10 microns; p = ns); medial thickness was also unchanged.
These data confirm the protective effect of NO in vascular injury and suggest that NO synthase activity is either absent or reduced to such a level that further inhibition in this short time course is not relevant to the pathophysiology of vein graft intimal hyperplasia.
静脉移植物植入动脉循环后的普遍反应是内膜增生的发展,即平滑肌细胞增殖和结缔组织沉积,这可能部分受功能失调的内皮一氧化氮(NO)代谢调节。本研究探讨单剂量、通过普朗尼克凝胶局部应用NO供体S-亚硝基-N-乙酰青霉胺(SNAP)和NO合酶抑制剂硝基-L-精氨酸甲酯(L-NAME)对内膜增生形成的影响。
40只新西兰白兔接受颈总动脉颈静脉间置移植术。
10只动物为对照组,10只动物的静脉移植物外表面涂有30%普朗尼克凝胶(2.5毫升),另外各10只在植入前于含10⁻³ M SNAP或L-NAME的乳酸林格液中浸泡15分钟,然后其静脉移植物涂有含SNAP(10⁻³ M)或L-NAME(10⁻³ M) 的2.5毫升凝胶,这可实现长达6小时的持续释放。术后第28天,处死动物并收获静脉移植物,通过电子显微镜(扫描电子显微镜和透射电子显微镜)进行形态学观察,并通过视频形态测量法进行尺寸分析。
所有静脉移植物均出现内膜增生。扫描电子显微镜下,静脉移植物有一层融合的内皮细胞,透射电子显微镜下可见多层平滑肌细胞代表内膜增生。四组之间无明显形态学差异。与仅用凝胶处理的组相比,SNAP局部治疗使平均内膜厚度显著降低36%(72±4微米对45±4微米;平均值±标准误;p<0.01),而中膜厚度无变化(58±6微米对61±7微米;p=无显著性差异)。L-NAME抑制NO合酶对内膜增生的发展无影响(72±4微米对79±10微米;p=无显著性差异);中膜厚度也未改变。
这些数据证实了NO在血管损伤中的保护作用,并表明NO合酶活性要么不存在,要么降低到如此程度,以至于在这个短时间过程中进一步抑制与静脉移植物内膜增生的病理生理学无关。